Home Cart Sign in  
Chemical Structure| 50370-12-2 Chemical Structure| 50370-12-2

Structure of Cefadroxil
CAS No.: 50370-12-2

Chemical Structure| 50370-12-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cefadroxil is the first-generation Cephalosporin antibiotic, which exerts bactericidal activity by interfering with the later stages of bacterial cell wall synthesis through inactivation of one or more penicillin-binding proteins and inhibiting cross-linking of the peptidoglycan structure.

Synonyms: BL-S 578

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cefadroxil

CAS No. :50370-12-2
Formula : C16H17N3O5S
M.W : 363.39
SMILES Code : O=C(C(N12)=C(C)CS[C@]2([H])[C@H](NC([C@H](N)C3=CC=C(O)C=C3)=O)C1=O)O
Synonyms :
BL-S 578
MDL No. :MFCD00865091
InChI Key :BOEGTKLJZSQCCD-UEKVPHQBSA-N
Pubchem ID :47965

Safety of Cefadroxil

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P280-P305+P351+P338-P310

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00332163 Metastatic Colorectal Cancer ... More >> Skin Rash Skin Toxicities Colon Cancer Colorectal Cancer Less << Phase 2 Completed - -
NCT00405158 Mastitis Not Applicable Completed - Sweden ... More >> Dept Obstetrics & Gynecology, Helsingborg Hospital Helsingborg, Skane, Sweden, 25187 Less <<
NCT02814916 Methicillin-Resistant Staphylo... More >>coccus Aureus Bacterial Infections Staphylococcal Skin Infections Less << Phase 3 Recruiting January 25, 2019 -
NCT00332163 - Completed - -
NCT02297815 - Completed - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02297815 - Completed - -
NCT01244698 Bacterial Infection ... More >> Anti-infective Agents Breast Implantation Less << Phase 4 Completed - United States, New York ... More >> Stony Brook University Medical Center Stony Brook, New York, United States, 11792 Less <<
NCT01845363 Obesity Phase 4 Completed - Brazil ... More >> Universidade Federal de Pernambuco - Hospital das Clínicas Recife, Pernambuco, Brazil, 50670901 Less <<
NCT00835081 Healthy Phase 1 Completed - United States, Texas ... More >> Bioassay Laboratory, Inc. Houston, Texas, United States, 77099 Canada, Ontario Biovail Contract Research Toronto, Ontario, Canada, M1L 4R6 Less <<
NCT00834275 - Completed - -
NCT00834275 Healthy Phase 1 Completed - United States, Texas ... More >> Bioassay Laboratory, Inc. Houston, Texas, United States, 77099 Canada, Ontario Biovail Contract Research Toronto, Ontario, Canada, M1L 4R6 Less <<
NCT02749981 - Completed - -
NCT02446496 Infections, Urinary Tract Phase 4 Completed - Egypt ... More >> GSK Investigational Site Cairo, Egypt Less <<
NCT02446496 - Completed - -
NCT00835081 - Completed - -
NCT02479867 Healthy PHASE1 COMPLETED 2025-04-14 Genuine Research Center GRC, C... More >>airo, Egypt Less <<
NCT02140281 Healthy Volunteers Phase 1 Completed - United States, Kansas ... More >> Research Site Overland Park, Kansas, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.75mL

0.55mL

0.28mL

13.76mL

2.75mL

1.38mL

27.52mL

5.50mL

2.75mL

References

 

Historical Records

Categories